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INTRODUCTION
Postmastectomy radiation therapy after total mastectomy has 
been shown to reduce the loco-regional recurrence rate and to 
increase overall survival in both early and advanced breast can-
cer patients [1,2]. While immediate breast reconstruction may 
improve quality of life for mastectomy patients, increased com-
plication rates are seen when the reconstructed breast is subject-
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ed to radiotherapy [3,4]. In a prospective cohort of irradiated 
breast cancer patients, the implant-based reconstruction group 
had double the odds of any complication compared to the au-
tologous breast reconstruction group at 2 years after surgery [3]. 
The observed complications include capsular contracture, infec-
tion, pain, skin necrosis, fibrosis, and impaired wound healing 
[5,6]. In particular, earlier studies reported that wound dehis-
cence occurred in 10%–23.5% of irradiated breasts, compared 
to 1%–2% in non-irradiated patients [6-8]. A higher rate of in-
fection is intimately linked to wound dehiscence, as implants are 
susceptible to infection because seeding can occur even through 
a small opening. Despite this, implant-based reconstruction ap-
pears to be on the rise globally, which is attributable to several 
factors, such as patients’ and physicians’ preferences, changes in 
oncologic practice, and the increased frequency of bilateral mas-
tectomies [9,10]. Therefore, developing strategies to mitigate 
these complications is of paramount importance.
Acellular dermal matrix (ADM) is widely used in implant-
based breast reconstruction surgery to cover the inferolateral 
pole of an implant for superior aesthetic outcomes, as well as in 
efforts to prevent capsular contracture [11,12]. A systematic re-
view found that ADM usage does not predispose irradiated pa-
tients to higher rates of complications when used to aid pros-
thetic breast reconstruction [13]. However, scant research has 
explored whether an ADM inlay graft can specifically support 
the incision site and prevent complications in irradiated breasts. 
In this study, the primary aim was to determine whether the use 
of an ADM inlay graft could prevent incisional dehiscence in ir-
radiated breasts. The secondary aim was to determine whether 
the use of an ADM inlay graft was related to other complica-
tions, such as infection or seroma.
METHODS
Patient selection
A retrospective study was conducted of patients who under-
went mastectomy followed by two-stage prosthetic breast re-
construction and postmastectomy radiotherapy between July 
2012 and August 2016 at our institute. Two cohorts were exam-
ined: patients with (n = 19) and without (n = 26) an ADM inlay 
graft at the incisional site during the second-stage operation. Af-
ter April 2015, ADM inlay grafts were applied when the amount 
of closing tension was high after implants were placed, with the 
intention of reinforcing the wound. Specifically, the incision was 
deemed to have high tension when it was located directly on or 
near the point of maximal projection after the permanent im-
plant was inserted. Two plastic surgeons (DWL and SYS) per-
formed all reconstructions. Patient information was collected 
from hospital electronic medical records, including demograph-
ic variables such as age, cancer stage, and body mass index, as 
well as information regarding the expanded volume of the tissue 
expander, permanent implant volume, chemotherapy, anti-es-
trogen therapy, target therapy, and complications. The institu-
tional review board approved this study design and the require-
ment for informed consent was waived (IRB No. 4-2018-1183). 
Reconstruction technique
All patients underwent total mastectomy or skin-/nipple-spar-
ing mastectomy performed by a breast oncologic surgeon, fol-
lowed by immediate breast reconstruction by a plastic surgeon. 
After mastectomy, a tissue expander was inserted into the sub-
pectoral plane and the lower lateral portion of the implant was 
covered with an ADM sling. The expander was prefilled with 
approximately one-third of the mastectomy volume. Expansion 
began 2 weeks after the operation and proceeded every 2 or 3 
weeks. Prior to radiation therapy, the expander was deflated to 
include only 150–250 mL of saline to make it less prominent in 
the supine position, thereby minimizing interference with post-
mastectomy radiotherapy [14]. Immediately following comple-
tion of radiation therapy, re-expansion was performed every 2 
or 3 weeks until the desired breast volume was reached.
The second stage of reconstruction took place at least 3 
months after the completion of radiation therapy and consisted 
of tissue expander removal with or without capsulectomy, fol-
lowed by insertion of a permanent shaped cohesive-gel silicone 
implant. The incision was made as short as possible (6 cm on 
average), considering the impaired wound healing in irradiated 
tissues. ADM (MegaDerm; 4 × 7 cm and 0.8–1.4 mm in thick-
ness; L&C Bio Corp., Seoul, Korea) was laid between the per-
manent implant and the expanded skin flap at the incisional site 
as an inlay graft to prevent incisional dehiscence in the ADM 
group. The ADM was fixed to the skin flap with Vicryl 3-0 pull-
out sutures. These marionette sutures were removed on postop-
erative day 7 (Fig. 1).
Radiation protocol
Radiation therapy commenced within 6 weeks after mastecto-
my or completion of the last cycle of chemotherapy. Prior to ra-
diotherapy, all patients underwent simulation computed tomog-
raphy scans for radiotherapy planning. The clinical target vol-
ume, including the ipsilateral chest wall, mastectomy scar, axil-
lary nodes, internal mammary lymph nodes, and supraclavicular 
lymph nodes, was contoured. Depending on the protocol cho-
sen by the radiation oncology team, patients received either 
conventional fractionation radiotherapy or hypofractionated ra-
diotherapy. Patients with the former radiotherapy protocol were 
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irradiated with 50.4 Gy in 28 fractions, while the prescription 
dose of the latter was 40.05 Gy in 15 daily fractions of 2.67 Gy.
Statistical analysis
When the data followed a normal distribution, continuous data 
were analyzed with the independent-samples t-test. Otherwise, 
the nonparametric Mann-Whitney test was used. The chi-
square or Fisher exact test was performed to analyze categorical 
data. Significance was set at P < 0.05, using IBM SPSS Statistics 
for Windows, version 23.0 (IBM Corp., Armonk, NY, USA) for 
all computations.
RESULTS
Forty-five breast cancer patients who underwent two-stage pros-
thetic (expander and implant) reconstruction with postmastec-
tomy radiotherapy were retrospectively examined. The demo-
graphic characteristics of patients in the non-ADM inlay graft 
and the ADM inlay graft group are illustrated in Table 1. The 
two groups were similar in age, body mass index, and preopera-
tive breast volume (P > 0.05). There were also no significant dif-
ferences between groups in the expanded expander volume, 
permanent implant volume, or the difference between those two 
values (P > 0.05). The two groups showed a similar distribution 
of additional therapy, such as neoadjuvant chemotherapy, adju-
vant chemotherapy, anti-estrogen therapy, and target therapy 
(P > 0.05). However, there was a significant difference between 
the two groups in the radiation protocol (P = 0.005).
The rates of complications were compared between the two 
groups (Table 2). Wound dehiscence occurred in six cases in the 
non-ADM inlay graft group, while no wound dehiscence was 
observed in the ADM inlay graft group (P = 0.032). Among the 
six operative revisions that were necessary in the non-ADM in-
lay graft group, two patients had implants downsized to reduce 
skin tension. Three other patients underwent reconstruction 
with a latissimus dorsi flap due to an unhealthy skin condition 
after repeated repairs. The last patient was treated with debride-
ment, and an ADM inlay graft was used to repair the dehiscence 
site for therapeutic purposes. Nine cases of capsular contracture 
(34.6%) occurred in the non-ADM inlay graft group, and four 
Characteristics
Non-ADM 
group 
(n=26)
ADM 
group 
(n=19)
P-value
Age (yr) 41.4±10.6 41.1±10.8 0.894
BMI (kg/m2) 21.6±2.9 20.9±2.5 0.179
Smoking 2 (7.7) 1 (5.3) >0.999
Interval between second operation 
and radiation therapy (mon)
291.8±312.2 216.8±54.5 0.510a)
Preoperative breast volume (mL) 365.0±143.5 361.1±105.7 0.921
Excised mastectomy skin (cm2) 44.4±33.2 52.9±45.1 0.510
Expanded volume (mL) 443.2±106.5 439.5±101.7 0.910
Permanent implant volume (mL) 358.2±89.0 313.2±66.6 0.143a)
Final stage 0.052
   I 8 (30.8) 3 (15.8)
   II 11 (42.3) 9 (47.4)
   III 7 (26.9) 7 (36.8)
   IV 0 0
Neoadjuvant chemotherapy 10 (38.5) 10 (52.6) 0.379
Adjuvant chemotherapy 14 (53.8) 10 (52.6) >0.999
Anti-estrogen therapy 20 (76.9) 13 (68.4) 0.734
Target therapy 0 2 (10.5) 0.173
Radiation protocol 0.005
   Conventional radiotherapy 11 (42.3) 16 (84.2)
   Hypofractionated radiotherapy 15 (57.7) 3 (15.8)
Follow-up period (mon) 41.7±16.7 30.7±4.5 0.171
Values are presented as mean±SD or number (%).
ADM, acellular dermal matrix; BMI, body mass index.
a)The statistical analysis was performed using the Mann-Whitney U test. The rest 
of the continuous variables were analyzed with the independent-samples t-test.
Table 1. Patients’ demographic characteristics
Complications Non-ADM group (n=26)
ADM group 
(n=19) P-value
Wound dehiscence   6 (23.1) 0 0.032
Capsular contracture   9 (34.6) 4 (21.1) 0.507
Cellulitis   1 (3.8) 3 (15.8) 0.295
Peri-prosthetic infection   2 (7.7) 0 0.501
Seroma/hematoma   0 0 -
Total complications 18 (69.2) 7 (36.8) 0.031
Needing major revisional 
surgery
  5 (19.2) 0 0.063
Values are presented as number (%).
Table 2. Postoperative complications
Acellular dermal matrix is laid between the permanent implant and 
the expanded skin flap on the incisional site in an inlay graft man-
ner. The skin flap, pectoral muscle and previously grafted acellular 
dermal matrix are sectioned along the meridian line.
Fig. 1. Acellular dermal matrix inlay graft
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cases of capsular contracture (21.1%) occurred in the ADM in-
lay graft group [15]. In the non-ADM group, three patients 
(9.4%) suffered from postoperative infections, two of whom 
had a peri-prosthetic infection instigated by wound dehiscence, 
which required implant change and a latissimus dorsi flap. In the 
ADM graft group, three cases (15.8%) of cellulitis occurred, 
which were accompanied by redness and heating of the skin en-
velope; these resolved with intravenous antibiotic therapy with-
in a week. No cases of seroma or hematoma were observed in ei-
ther group. The total complication rate, excluding wound dehis-
cence, was 46.2% in the non-ADM graft group, while it was only 
36.8% in the ADM graft group (P = 0.532). Furthermore, major 
revisional surgery to resolve the complications was needed in 
five patients (19.2%) in the non-ADM graft group and in none 
of the patients (0%) in the ADM graft group, but this difference 
did not achieve statistical significance (P = 0.063). 
DISCUSSION
Previously, breast reconstruction with a prosthetic device com-
bined with irradiation was a relative contraindication due to the 
high reconstruction failure rate of 37% and the corresponding 
negative impact on patient satisfaction [3,5,16]. Radiation not 
only increases complications, such as early wound healing prob-
lems and late capsular contracture, but also often results in a 
high-riding nipple and implant malposition [17]. Recently, 
complications and aesthetic results in implant-based reconstruc-
tion of irradiated breasts have improved to acceptable rates 
when compared to prior studies, with technical improvements 
including muscular coverage, use of ADM, newer prostheses, 
and modern radiation therapy protocols [18]. The use of ADM 
can provide aesthetic and psychological benefits, without affect-
ing the complication rate in irradiated breasts [13]. Although 
Pestana et al. [19] suggested that ADM may increase complica-
tions requiring reoperation, they did not take into consideration 
whether radiation therapy took place before or after the recon-
struction.
Although the volume of the permanent implants used in this 
study typically did not exceed that of the expander, tension 
upon wound closure can also be affected by the relative location 
of the incision in relation to the point of maximal projection. 
Wound dehiscence usually occurred at the maximal projection 
point of the implant, where the skin tension is the highest. Pre-
viously, Nahabedian [20] suggested making a new incision at 
the inframammary fold, instead of using the previous mastecto-
my incision to decrease the chance of wound dehiscence. Al-
though the inferolateral inframammary fold incision is not re-
markable, patients and reconstructive surgeons want to avoid 
additional scars if possible. In this study, application of ADM to 
the incisional site as an inlay graft decreased the rate of wound 
dehiscence. The grafted site of ADM was underneath the ex-
panded skin flap, submuscular capsule, or previously taken 
ADM capsule, depending on the position of the incision. The 
ADM inlay graft is expected to take well regardless of the graft 
site, because ADM is grafted onto the capsule, which is a well-
vascularized tissue.
Chronic injury of the soft tissue after radiation therapy is con-
sidered to occur due to the pathogenic fibroatrophic effect of ra-
diation, which results in low tensile strength of the tissue [21]. 
Endothelial cell injury, vascular dysfunction, altered expression 
of bioactive cytokines including transforming growth factor-be-
ta 1, and oxidative stress lead to excessive extracellular matrix 
deposition of collagen I and III, a persistent excess of myofibro-
blasts, and gradual fibroblast rarefaction combined with incom-
plete cell replacement [22]. As described by Cordeiro et al. [23], 
two-stage postmastectomy reconstruction with expanders and 
implants has a higher rate of failure at the second stage, but 
yields improved aesthetic outcome in the setting of postmastec-
tomy radiation therapy compared with direct-to-implant recon-
struction. The ADM inlay graft may be considered a strategy to 
mitigate these complications and reconstructive failure, as dem-
onstrated by our results. We propose several speculative hypoth-
eses regarding how an ADM inlay graft may prevent incisional 
dehiscence. First, the ADM inlay graft may act as a mechanical 
buttress to offload skin tension in a pants-over-vest fashion. The 
marionette stitches and ADM graft may relieve tension on the 
incision, improving blood supply to the wound. In a similar 
manner, ADM is often used for repair of ventral hernias to rein-
force and offload tension on fascial closures [24]. Secondly, the 
ADM inlay graft may serve as a scaffold for wound regeneration, 
as ADM is already known to promote chronic wound healing 
[25]. Third, the ADM inlay graft can act as an additional barrier 
between the prosthetic and external environment. In non-graft-
ed patients, wound complications may lead to severe peri-pros-
thetic infections that require operative interventions. The addi-
tional barrier provided by the ADM inlay graft reduced opera-
tive complications to 0%.
This is the first study, as far as the authors are aware, in which 
ADM was placed as an inlay graft manner to prevent wound de-
hiscence in irradiated breasts. The limitations of this study in-
clude its retrospective design, in which the patients were not ran-
domly assigned to groups. Furthermore, as we analyzed a series 
of consecutive patients, the distribution of the radiation protocol 
was different between the ADM and non-ADM groups. Our ra-
diation oncologists began using a hypofractionated radiation 
technique in the middle of the study period, resulting in an im-
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balance between the two groups in the radiation protocol. How-
ever, the relationship between hypofractionated radiotherapy 
and breast reconstruction has not been delineated [25]. Even if 
hypofractionated radiotherapy affected the complication rate of 
reconstructions, we believe that the ADM inlay graft is an ideal 
and easy to replicate technique for preventing incisional dehis-
cence in prosthetic reconstruction in the setting of postmastec-
tomy radiation. Additional prospective trials with larger groups 
are required in the future for further verification of our findings.
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